TMCnet News
NinePoint Medical Announces Substantial Hospital Reimbursement Increase for Procedures Using the NvisionVLE® Imaging System with Real-time Targeting™NinePoint Medical, Inc., a transformative medical device company pioneering the use of an advanced imaging platform for gastrointestinal applications, announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has published its 2017 final fee schedule. The annual update includes a material increase to the reimbursement rate for CPT Code 432521 (upper GI endoscopy with optical endomicroscopy), used for esophageal procedures using the NvisionVLE Imaging System with Real-time Targeting. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161115005471/en/ The NvisionVLE® Imaging System with Real-time Targeting™ enables physicians to evaluate tissue microstructure and mark areas of interest that may not be visible with conventional medical imaging technologies during a standard endoscopy procedure. (Photo: Business Wire) According to the final 2017 CMS fee schedule, starting January 1, 2017, the reimbursement rate for CPT code 43252 in the hospital out-patient setting increases 131% from $1,088.00 to $2,509.64, while the reimbursement rate for the same code in the ambulatory surgical center (ASC (News - Alert)) setting increases 86% from $608.9 to $1,134.02. The NvisionVLE Imaging System with Real-time Targeting employs proprietary Optical Coherence Tomography (OCT) technology allowing physicians to perform a Volumetric Laser Endomicroscopy procedure that produces real-time, high-resolution cross-sectional images. The system enables physicians to evaluate and mark tissue for potential disease that may not be visible with conventional medical imaging technologies such as white light endoscopy or ultrasound. "The decision to increase reimbursement rates helps to validate the clinical need and benefit of using OCT in upper GI procedures," commented Christopher R. von Jako, Ph.D., President and CEO of NinePoint Medical. "This economic improvement can help physicians bring our technology to more patients who suffer from esophageal disease."
About Esophageal Disease
About the NvisionVLE® Imaging System
About NinePoint Medical, Inc.
References:
View source version on businesswire.com: http://www.businesswire.com/news/home/20161115005471/en/ |